Bryostatin 1, a Novel Antineoplastic Agent and Protein Kinase C Activator, Induces Human Myalgia and Muscle Metabolic Defects: A 31P Magnetic Resonance Spectroscopic Study

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1995.449
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Differential Modulation of Protein Kinase C by Bryostatin 1 and Phorbol Ester.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1988English

A Quantitative Study of Bioenergetics in Skeletal Muscle Lacking Carbonic Anhydrase III Using 31P Magnetic Resonance Spectroscopy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

The Effects of Taurolidine, a Novel Antineoplastic Agent, on Human Malignant Mesothelioma

Clinical Cancer Research
Cancer ResearchOncology
2004English

31p-Magnetic Resonance Spectroscopy of Leg Muscle Metabolism During Exercise in Children and Adults

Journal of Applied Physiology
MedicinePhysiologySports Science
1993English

31P Magnetic Resonance Phospholipid Profiles of Neoplastic Human Breast Tissues

British Journal of Cancer
Cancer ResearchOncology
1991English

31P Nuclear Magnetic Resonance Studies of High Energy Phosphates and pH in Human Muscle Fatigue. Comparison of Aerobic and Anaerobic Exercise.

Journal of Clinical Investigation
Medicine
1988English

Anticancer Activity of Streptochlorin, a Novel Antineoplastic Agent, in Cholangiocarcinoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Activator Protein-1 (AP-1) Signalling in Human Atherosclerosis: Results of a Systematic Evaluation and Intervention Study

Clinical Science
Medicine
2012English

Protein Kinase C Θ Activation Induces Insulin-Mediated Constriction of Muscle Resistance Arteries

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy